Vaccination Recommendations for Adults Flashcards

1
Q

influenza vaccine type

A
  • inactivated
  • live attenuated
  • recombinant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

influenza ACIP recommendation

A
  • annual for anyone ≥ 6 months of age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

tetanus, diphtheria, pertussis vaccine type

A
  • inactivated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

tetanus, diphtheria, pertussis ACIP recommendation for adults

A
  • primary series for unvaccinated adults
  • Td booster every 10 years for all adults
  • one-time pertussis booster w/ Tdap for all adults
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

tetanus, diphtheria, pertussis ACIP recommendation for pregnant women

A
  • all pregnant women 27-36 weeks gestation during EACH pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

varicella vaccine type

A
  • live attenuated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

varicella ACIP recommendation

A
  • 2 doses ≥ 4 weeks apart for anyone w/o VZV immunity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

herpes zoster vaccine type

A
  • inactivated

- live attenuated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

herpes zoster ACIP recommendation

A
  • inactivated –> anyone ≥ 50 yoa

- live attenuated –> all immunocompromised pts ≥ 60 yoa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

pneumococcal vaccine type

A
  • inactivated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

pneumococcal ACIP recommendation

A
  • all adults ≥ 65 yoa

- 19-64 yoa WITH risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

if pt ≥ 65 yoa NEVER received pneumococcal vaccine, wtd?

A
  • PCV13 (conjugate) once

- then PPSV23 (polysaccharide) at least 1 year after

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

if received PPSV23 at or after 65 yoa, wtd?

A
  • PCV13 once at least 1 year after last PPSV23 vaccine given
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

if received PPSV23 before 65 yoa, wtd?

A
  • PCV13 once at least 1 year after last PPSV23 vaccine given

- then another PPSV23 at least 1 year after

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

human papillomavirus vaccine type

A
  • inactivated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

human papillomavirus ACIP recommendation for females

A
  • vaccinate from 11 to 26 yoa
17
Q

human papillomavirus ACIP recommendation for males

A
  • vaccinate from 11 to 26 yoa
18
Q

human papillomavirus ACIP recommendation for immunocompromised pts (including HIV pts) and MSM persons

A
  • vaccinate up to 26 yoa
19
Q

measles, mumps, rubella vaccine type

A
  • live attenuated
20
Q

measles, mumps, rubella ACIP recommendation

A
  • if born in 1957 or later w/o evidence of vaccination or immunity
  • one dose usually suficient
21
Q

measles, mumps, rubella ACIP recommendation for 2nd dose

A
  • college students
  • international travelers
  • HCWs
22
Q

measles, mumps, rubella ACIP recommendation for 3rd dose

A
  • pts at increased risk during outbreak
23
Q

meningococcal serogroups A, C, W135, and Y vaccine type

A
  • inactivated
24
Q

meningococcal serogroups A, C, W135, and Y ACIP recommendation for 1 dose

A
  • 1st year college students in dorms (unless already vaccinated at ≥ 16 yoa, travelers to endemic areas, microbiologists exposed to N. meningitidis, military recruits, exposed persons
25
Q

meningococcal serogroups A, C, W135, and Y ACIP recommendation for 2 doses

A
  • pts w/ asplenia or complements deficiencies

- HIV pts

26
Q

meningococcal serogroups A, C, W135, and Y ACIP recommendation for revaccination

A
  • every 5 years if persistent risk
27
Q

meningococcal serogroup B vaccine type

A
  • inactivated
28
Q

meningococcal serogroup B ACIP recommendation for 2 doses

A
  • anatomic/functional asplenia
  • persistent complement deficiencies
  • eculizumab use
  • microbiologists exposed to N. meningitidis
  • increased risk during outbreak
29
Q

hepatitis A vaccine type

A
  • inactivated
30
Q

hepatitis A ACIP recommendation

A
  • any adult requesting immunization

- if high risk

31
Q

hepatitis A vaccine type

A
  • inactivated
32
Q

hepatitis B ACIP recommendation

A
  • any adult requesting immunization

- if high risk

33
Q

contraindications to live vaccines

A
  • pregnancy
  • HIV or AIDS w/ CD4 cell count ≤ 200/µL or ≤ 15% of total lymphocytes
  • immunosuppressant therapy, including high-dose glucocorticoids (≥ 20 mg/d of prednisone or equivalent)
  • leukemia, lymphoma, or other bone marrow and lymphatic system malignancies
  • cellular immunodeficiency
  • solid-organ transplant recipient
  • current hematopoietic stem cell transplantation